SUMMARY Three cases of embryonal orbital rhabdomyosarcoma are presented in which two cases had intracranial extension. All three are alive and well on follow-up several years after completing a 12-month course of combined pulsed chemotherapy and irradiation. The improved prognosis even in parameningeal involvement is emphasised.
tOctober 1984. plinary team approach in the management of such cases is essential. We report three cases which presented in the West of Scotland. All three patients are alive and well after completing a 12-month combined therapy course (Table 1) .
Case reports CASE 1
An 8-year-old girl presented on 28 September 1979 with painful proptosis of the right eye and marked chemosis as well as restriction of movement on dextroversion (Fig. 1) . The visual acuity in the right eye was 6/6 and in the left 6/9. A retrobulbar mass was suspected; a biopsy proved the lesion to be a rhabdomyosarcoma. X-ray of the orbit, tomography, ultrasound, and CT scan disclosed destruction of the lateral wall and inferior margin of the right orbit as ance of the undifferentiated rhabdomyosarcoma cells lacking the z banding found in this tumour and that of the primitive mesodermal cells in the extraocular muscle of a 9-10 cm human embryo.
On completion of the chemotherapy regimen the right socket was markedly contracted, and cosmetic reconstruction with dermofat graft was successfully done. Later side effects included recurrent epistaxis and sinusitis. CASE 2 A 7-year-old boy presented in February 1981 with a painful right eye and two days later developed proptosis, ptosis, and limited ocular movement on adduction. The condition was initially thought to be related to ocular trauma sustained two days earlier.
The visual acuity in the right eye was only hand movements and in the left eye was 6/6. In four days the right visual acuity deteriorated to no perception of light, and the right disc had become swollen. Right orbitotomy biopsy showed the swelling to be an embryonal rhabdomyosarcoma. CT scan showed this intraorbital lesion to be associated with erosion of the posterior and inferior orbital walls and maxillary antrum as well as intracranial extension into the middle cranial fossa. Investigations excluded metastasis to the lungs, skeleton, bone marrow, and cerebrospinal fluid. By the staging criteria of the American Intergroup Rhabdomyosarcoma Study the disease was classified as stage III.
Initial radiotherapy to the cranium only was given in a dose of 3000 rads over four weeks, followed by 2500 rads to the right orbit and cavernous sinuses over three weeks. Intravenous pulsed chemotherapy with vincristine (1-6 mg/m2), cyclophosphamide (200 mg/M2), and actinomycin D (0.3 mg/M2) was followed by methotrexate (12 mg), cytosine arabinoside (50 mg), and hydrocortisone (25 mg). In addition intrathecal hydrocortisone (25 mg), methotrexate (12 mg), and cytosine arabinoside (50 mg) were administered at weekly intervals for eight weeks. Tumour regression was noted and monitored with CT scan. Six months later, however, the right eye developed painful keratitis, and on suspicion of endophthalmitis it was eviscerated. The chemotherapy regimen was continued until March 1982. Follow-up since then has shown no recurrence of the lesion. General side effects of this regimen included infection and stomatitis. Impairment of gait was attributed to vincristine neuropathy. ... aL gr globe was noted. X-ray showed an enlarged orbit. Anterior orbitotomy exploration revealed a pearly mass lying subperiosteally with bone destruction in the superolateral region of the orbit. Biopsy showed this to be an undifferentiated rhabdomyosarcoma (Fig. 3) . A CT scan showed in addition extension to the middle cranial fossa and temporal fossa (Fig. 4) Extension into parameningeal sites occurred in two cases. The CT scan is one of the best investigative tools not only for delineating the extent of such involvement but also for monitoring the effects of treatment. The importance of adequate treatment at this site cannot be overemphasised, as the meninges constituted the initial site of the disease recurrence.P rimary rhabdomyosarcoma of the midcranial fossa itself is extremely rare. "
Recent multiple therapeutic approaches which aim to conserve the eye with a planned programme to treat each case in an individual manner should give an even better prognosis. 12 However, complications continue to occur with each type of treatment. Radiation keratitis and suspected endophthalmitis led to enucleation and evisceration in two of our cases. A contracture socket deformity needed further reconstruction. The systemic side effects of cytotoxic drugs included epistaxis, neutropenia, abdominal pain, and stomatitis, and in one case neuropathy due to vincristine. 13 One could only speculate that perhaps the longer duration of the irradiation fractionation pattern was beneficial in case 3.
Long-term complications of radiotherapy as a treatment of rhabdomyosarcoma have not been reported for orbital lesions, though reports of osteogenic sarcoma of the mandible and hypopituitarism after irradiation of nasopharyngeal rhabdomyosarcoma exist. ' Future developments in the management of this condition reside in reducing the toxicity of the present chemotherapeutic drugs. 14 A recent approach involves the use of drugs to block the renal and bladder toxicity of cyclophosphamide. Another approach uses drugs such as lithium carbonate to stimulate the marrow production of leucocytes, thus reducing the marrow suppression of cytotoxic drugs. It has also been suggested that the development of analogues may reduce the toxicity of the active structure of cytotoxic drugs used in the treatment of rhabdomyosarcoma in children. The use of folic acid rescue' following massive doses of methotrexate is still under investigation and its value is unproved.
